Consolidated statement of cash flows
(In € million) |
|
Note |
|
Year ended |
|
Year ended |
---|---|---|---|---|---|---|
Cash flows from operating activities |
|
|
|
|
|
|
Profit for the period |
|
|
|
37.8 |
|
172.1 |
Adjustments for: |
|
|
|
|
|
|
Depreciation and amortisation |
|
|
366.7 |
|
306.6 |
|
Impairment losses |
|
|
6.3 |
|
4.4 |
|
Net change in fair value of operating derivatives |
|
|
|
39.5 |
|
(7.4) |
Realised gain on settlement of deal-contingent derivatives |
|
|
(16.6) |
|
– |
|
Share-based payment expense |
|
|
5.4 |
|
3.8 |
|
Gain on sale of property, plant and equipment and |
|
|
|
(0.5) |
|
(0.8) |
Loss on sale of subsidiary |
|
|
– |
|
12.1 |
|
Gain on pre-existing interest in former joint ventures |
|
|
– |
|
(48.8) |
|
Share of loss of joint ventures |
|
|
– |
|
1.6 |
|
Net finance expense |
|
|
26.0 |
|
31.4 |
|
Interest paid |
|
|
|
(52.2) |
|
(40.6) |
Payment of transaction and other costs relating to financing |
|
|
(3.3) |
|
– |
|
Income tax expense |
|
|
51.0 |
|
52.3 |
|
Income taxes paid, net of refunds received |
|
|
|
(94.4) |
|
(73.0) |
|
|
|
|
365.7 |
|
413.7 |
Change in trade and other receivables |
|
|
|
(34.0) |
|
(4.0) |
Change in inventories |
|
|
|
(53.1) |
|
(9.4) |
Change in trade and other payables |
|
|
|
234.3 |
|
62.5 |
Change in provisions and employee benefits |
|
|
|
(14.4) |
|
14.9 |
Change in other assets and liabilities |
|
|
|
79.7 |
|
53.2 |
Net cash from operating activities |
|
|
578.2 |
|
530.9 |
|
Cash flows from investing activities |
|
|
|
|
|
|
Acquisition of businesses, net of cash acquired |
|
|
(700.4) |
|
(63.6) |
|
Settlement of deal-contingent derivatives |
|
|
61.1 |
|
– |
|
Sale of subsidiary, net of cash disposed of |
|
|
– |
|
3.1 |
|
Acquisition of property, plant and equipment and intangible assets |
|
|
(299.7) |
|
(245.9) |
|
Proceeds from sale of property, plant and equipment and other assets |
|
|
19.1 |
|
1.1 |
|
Proceeds from sale of securities |
|
|
|
0.4 |
|
– |
Interest received |
|
|
|
1.6 |
|
1.5 |
Net cash used in investing activities |
|
|
(917.9) |
|
(303.8) |
|
Cash flows from financing activities |
|
|
|
|
|
|
Proceeds from issue of shares |
|
|
203.5 |
|
– |
|
Payment of costs for placement of shares |
|
|
(3.6) |
|
– |
|
Proceeds from loans and borrowings |
|
|
1,710.0 |
|
100.0 |
|
Repayment of loans and borrowings |
|
|
(1,189.0) |
|
(239.5) |
|
Settlement of deal-contingent derivative |
|
|
15.5 |
|
– |
|
Payment of lease liabilities |
|
|
(34.5) |
|
(26.7) |
|
Purchase of treasury shares |
|
|
(16.3) |
|
(0.7) |
|
Payment of dividends |
|
|
(147.9) |
|
(128.1) |
|
Other |
|
|
|
1.1 |
|
1.4 |
Net cash from/(used in) financing activities |
|
|
538.8 |
|
(293.6) |
|
Net increase/(decrease) in cash and cash equivalents |
|
|
|
199.1 |
|
(66.5) |
Cash and cash equivalents as of the beginning of the period |
|
|
|
304.5 |
|
355.1 |
Effect of exchange rate fluctuations on cash and cash equivalents |
|
|
|
0.2 |
|
15.9 |
Cash and cash equivalents as of the end of the period |
|
|
503.8 |
|
304.5 |